KR900017587A - 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도 - Google Patents

바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도 Download PDF

Info

Publication number
KR900017587A
KR900017587A KR1019890006509A KR890006509A KR900017587A KR 900017587 A KR900017587 A KR 900017587A KR 1019890006509 A KR1019890006509 A KR 1019890006509A KR 890006509 A KR890006509 A KR 890006509A KR 900017587 A KR900017587 A KR 900017587A
Authority
KR
South Korea
Prior art keywords
tiprotimod
manufacture
therapeutic agent
viral infection
thiazole derivative
Prior art date
Application number
KR1019890006509A
Other languages
English (en)
Inventor
울리히 쇼를렘머 한스
하르알트 세드라세크 한스
힐펜하우스 요아힘
Original Assignee
필립 스타인, 헤리베르트 부크
베링베르케 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 필립 스타인, 헤리베르트 부크, 베링베르케 아크티엔게젤샤프트 filed Critical 필립 스타인, 헤리베르트 부크
Publication of KR900017587A publication Critical patent/KR900017587A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

내용 없음

Description

바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 바이러스 감염증 치료용 약제 제조를 위한 티포로티모드의 용도.
  2. 제1항에 있어서, 바이러스가 허피스 심플렉스 또는 EMC 바이러스일때 티프로티모드의 용도.
  3. 제1항에 있어서, 체중 kg당 0.1 내지 100mg, 바람직하게는 0.5 내지10mg의 티프로티모드를 함유하는 약제에서 티프로티모드의 용도.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019890006509A 1988-05-16 1989-05-16 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도 KR900017587A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3816603A DE3816603A1 (de) 1988-05-16 1988-05-16 Verwendung des thiazol-derivates tiprotimod zur herstellung eines mittels zur therapie von virusinfektionen
DEP3816603.8 1988-05-16

Publications (1)

Publication Number Publication Date
KR900017587A true KR900017587A (ko) 1990-12-19

Family

ID=6354444

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890006509A KR900017587A (ko) 1988-05-16 1989-05-16 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도

Country Status (11)

Country Link
US (1) US4963577A (ko)
EP (1) EP0342565B1 (ko)
JP (1) JPH0217123A (ko)
KR (1) KR900017587A (ko)
AT (1) ATE92760T1 (ko)
AU (1) AU621110B2 (ko)
CA (1) CA1328616C (ko)
DE (2) DE3816603A1 (ko)
DK (1) DK235089A (ko)
ES (1) ES2059615T3 (ko)
PT (1) PT90560B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
TW252112B (ko) * 1993-08-19 1995-07-21 Pfizer
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7001928A (ko) * 1969-02-11 1970-08-13
BE850148A (fr) * 1977-01-06 1977-07-06 American Cyanamid Co Procede pour prevoir ou traiter les infections a rhinovirus
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren

Also Published As

Publication number Publication date
AU621110B2 (en) 1992-03-05
DK235089A (da) 1989-11-17
AU3474989A (en) 1989-11-16
DE3816603A1 (de) 1989-11-30
PT90560A (pt) 1989-11-30
EP0342565A2 (de) 1989-11-23
EP0342565A3 (de) 1991-02-06
ES2059615T3 (es) 1994-11-16
US4963577A (en) 1990-10-16
DK235089D0 (da) 1989-05-12
JPH0217123A (ja) 1990-01-22
CA1328616C (en) 1994-04-19
EP0342565B1 (de) 1993-08-11
DE58905219D1 (de) 1993-09-16
ATE92760T1 (de) 1993-08-15
PT90560B (pt) 1994-08-31

Similar Documents

Publication Publication Date Title
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
DK602988D0 (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
KR950703953A (ko) 2-아미노-6-n-프로필아미노-4, 5, 6, 7-테트라하이드로벤조티아졸(프라미펙솔)의 항우울제로서의 용도(Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexol)as an antidepressant drug)
KR890015742A (ko) 이병치료용 국소 제제
KR900017587A (ko) 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
KR890003374A (ko) 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용
DK178188D0 (da) Antivirusmiddel
KR890009401A (ko) 바이러스를 억제시키는 방법
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
ES8608884A1 (es) Un procedimiento de eliminacion del virus lav.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
KR960006920A (ko) 혈액 항응고제에 대한 해독제로서 사용하기에 적합한 약제 및 이의 용도
KR950700315A (ko) 이중 작용을 하는 2',5'-올리고아데닐레이트 항비루스성 유도체와 그의 용도
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
RU93058325A (ru) Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита в
WO1988007367A3 (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
JPS55113721A (en) Immunity regulator
KR890005140A (ko) 항비루스제
KR890001543A (ko) 당뇨병 치료제
DK0459176T3 (da) Oligophosphater med antiviral virkning
KR890701582A (ko) 치료용 뉴클레오사이드
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR900005991A (ko) 옥트레오티드(Octreotide)를 함유한 약학적 조성물
KR920019362A (ko) 디데옥시 아데노신 및 아데노신 데아미나제 억제물질을 포함하는, 항-hiv활성을 지닌 치료학적 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application